OrthoSpineNews

MARCH 3, 2025

This event marks the beginning of SST’s U.S.-based based trial to evaluate its PerQdisc system for patients suffering from degenerative disc disease (DDD). patient in its Investigational Device Exemption (IDE) clinical trial for the PerQdisc Nucleus Replacement Device (NRD).

Degenerative Disc Disease 52

Degenerative Disc Disease Patients Spine Clinic 52

OrthoSpineNews

MAY 13, 2025

No serious adverse events (SAEs) were reported, and there was no dose (40X10 6 cells) limiting toxicity at 26-104 weeks. We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure.

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Clinic Spine 52

ChiroTouch

JULY 19, 2024

Today’s chiropractors use an impressive array of chiropractic tools and equipment designed to enhance diagnosis, treatment, and prevention of a wide range of conditions. The cushioned handle and trigger provide comfort and protection for the practitioner’s hand, ensuring ease of use during treatments. Stationary tables.

X-ray 98

X-ray Soft Tissue Injuries Vertebrae Chiropractic 98

Any Spine

SEPTEMBER 30, 2024

Clinical trials have shown the effectiveness of chiropractic spinal adjustments in reducing pain, including issues in the shoulder area, often providing a complementary option alongside other treatments like acupuncture. These practices aim to improve spinal health, which is crucial for overall well-being.

Spinal Adjustment 52

Spinal Adjustment Adjustment Chiropractic Degenerative Disc Disease 52

OrthoSpineNews

JUNE 13, 2025

Excellent Safety Profile: No serious adverse events (SAEs) or dose-limiting toxicities reported between 26 and 104 weeks at the target dose (40 million cells). About the BRTX-100 Phase 2 Trial BRTX-100 is a novel, autologous cell-based therapy designed to treat patients suffering from painful lumbosacral disc degeneration.

Degenerative Disc Disease 64

Degenerative Disc Disease Lower Back Pain Clinic Treatment 64

OrthoSpineNews

MARCH 10, 2025

The REFINE study, designed to bridge the gap between conservative treatments and more invasive surgical options, has successfully enrolled its full cohort of patients across multiple centers in the United States. CARLSBAD, Calif., We are incredibly proud to reach this milestone, said Trent Northcutt, President and CEO of Aurora Spine.

Degenerative Disc Disease 52

Degenerative Disc Disease Spine Clinic Musculoskeletal 52

OrthoSpineNews

MAY 14, 2025

Disc/Spine Program In a February podium presentation at the Orthopaedic Research Society (ORS) Annual Meeting, BioRestoratives Vice President of Research and Development, Francisco Silva, presented 2652 week blinded data from the first 15 patients with chronic lumbar disc disease (cLDD) enrolled in the ongoing Phase 2 clinical trial of BRTX-100.

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Neck Pain Treatment 52